low cost glp 1 New Medicare GLP-1 Bridge Program Launching July 1, 2026 How Employers Can Manage GLP-1
Description
References 1 World Health Organization [WHO]
Glucagon-like peptide analogs are superior for diabetes and weight control in patients on antipsychotic medications: a retrospective cohort study
BMJ 363:k4365
SGLT2 inhibitors, a related medication, were initially approved for diabetes, but then subsequently had indications added for heart failure and chronic kidney disease
In this study, we saw disruptions were particularly pronounced among AOM users, peaking in late 2023
